Fulcrum Therapeutics, Inc.
US ˙ NasdaqGM ˙ US3596161097

SecurityFULC / Fulcrum Therapeutics, Inc.
InstitutionFiduciary Trust Co
Latest Disclosed Ownership136,555 shares
Latest Disclosed Value $ 1,047,377
Fiduciary Trust Co ownership in FULC / Fulcrum Therapeutics, Inc.

On May 15, 2026 - Fiduciary Trust Co filed a 13F-HR form disclosing ownership of 136,555 shares of Fulcrum Therapeutics, Inc. (US:FULC) valued at $1,047,377 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 136,555 shares of Fulcrum Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $460,190 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 1,047 -32.19 0.0072
2026-02-13 2025-12-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 1,544 22.93 0.0176
2025-11-14 2025-09-30 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 1,256 33.76 0.0142
2025-08-14 2025-06-30 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 939 138.93 0.0116
2025-05-15 2025-03-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 393 -38.69 0.0052
2025-02-14 2024-12-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 642 31.62 0.0085
2024-11-14 2024-09-30 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 488 -42.43 0.0068
2024-08-14 2024-06-30 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 847 -34.37 0.0127
2024-05-14 2024-03-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 1,289 39.96 0.0198
2024-02-12 2023-12-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 922 51.98 0.0154
2023-11-14 2023-09-30 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 606 34.67 0.0111
2023-08-01 2023-06-30 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 451 15.68 0.0079
2023-05-15 2023-03-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 0 0.00 389 -60.87 0.0072
2023-02-14 2022-12-31 13F FULCRUM THERAPEUTICS COM 359616109 136,555 4,083 3.08 994 -7.28 0.0193
2022-11-14 2022-09-30 13F FULCRUM THERAPEUTICS COM 359616109 132,472 0 0.00 1,072 65.18 0.0232
2022-08-12 2022-06-30 13F FULCRUM THERAPEUTICS COM 359616109 132,472 0 0.00 649 -79.29 0.0137
2022-05-12 2022-03-31 13F FULCRUM THERAPEUTICS COM 359616109 132,472 0 0.00 3,133 33.72 0.0562
2022-02-14 2021-12-31 13F FULCRUM THERAPEUTICS COM 359616109 132,472 3,257 2.52 2,343 -35.72 0.0385
2021-11-12 2021-09-30 13F FULCRUM THERAPEUTICS COM 359616109 129,215 3,216 2.55 3,645 176.14 0.0649
2021-08-16 2021-06-30 13F FULCRUM THERAPEUTICS COM 359616109 125,999 1,000 0.80 1,320 -10.33 0.0255
2021-05-19 2021-03-31 13F FULCRUM THERAPEUTICS COM 359616109 124,999 0 0.00 1,472 0.55 0.0299
2021-01-26 2020-12-31 13F FULCRUM THERAPEUTICS COM 359616109 124,999 0 0.00 1,464 47.73 0.0305
2020-11-13 2020-09-30 13F FULCRUM THERAPEUTICS COM 359616109 124,999 0 0.00 991 -56.65 0.0233
2020-08-13 2020-06-30 13F FULCRUM THERAPEUTICS COM 359616109 124,999 0 0.00 2,286 53.22 0.0566
2020-05-15 2020-03-31 13F FULCRUM THERAPEUTICS COM 359616109 124,999 104,999 525.00 1,492 348.05 0.0433
2020-02-04 2019-12-31 13F FULCRUM THERAPEUTICS COM 359616109 20,000 10,000 100.00 333 404.55 0.0078
2019-11-12 2019-09-30 13F FULCRUM THERAPEUTICS COM 359616109 10,000 10,000 66 0.0017
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.